Barry D. Quart, Director at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 43,918 shares at $16.15 ($709K) on 2022-11-29, disclosed to the SEC on 2022-12-01.
Open-market sale of $709k KNSA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.15 | 21,959 | $355K | 50.0% |
| 2 | $16.15 | 21,959 | $355K | 50.0% |
| Total | $16.15 avg | 43,918 | $709K | 100% |
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |